Editorial: Biomarkers of response to interventions in psychiatry
Mental disorders remain among the leading causes of disability and premature mortality worldwide, with a growing burden across both high-income and low-and middle-income countries. Despite substantial advances in pharmacological and psychosocial treatments, clinical decision-making in psychiatry continues to rely heavily on subjective symptom reports and trial-and-error approaches. This limitation has fueled increasing interest
Authors
- Ricardo Riyoiti Uchida (ORCID: https://orcid.org/0000-0002-4209-8830)
- Kevin Pacheco-Barrios
- Sara B. Franco
- Lucas Murrins Marques
Institutions
- Harvard University (US)
- Universidad San Ignacio de Loyola (PE)
- Spaulding Rehabilitation Hospital (US)
- Dutch Health Care Inspectorate (NL)
- Massachusetts General Hospital (US)
- Faculdade de Ciências Médicas da Santa Casa de São Paulo (BR)
- Artificial Intelligence in Medicine (Canada) (CA)
Publication Details
- Journal
- Frontiers in Psychiatry
- Published
- 2026-01-22
- DOI
- https://doi.org/10.3389/fpsyt.2026.1770939
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00